Irbesartan
Published date: 2018-07-17 11:54:10
|
Name | Irbesartan | CAS# | 138402-11-6 |
|---|---|---|---|---|
| Price | $Inquiry/1kg | Purity | 99.9% | |
| Stocking Period |
Inquiry | Stock | In Stock |
| Detail
Product Information
Names [ Name ]: irbesartan [ Synonym ]: More Synonyms Chemical & Physical Properties [ Density ]: 1.3±0.1 g/cm3 [ Boiling Point ]: 648.6±65.0 °C at 760 mmHg [ Melting Point ]: 180-181°C [ Molecular Formula ]: C25H28N6O [ Molecular Weight ]: 428.529 [ Flash Point ]: 346.0±34.3 °C [ Exact Mass ]: 428.232452 [ PSA ]: 87.13000 [ LogP ]: 4.51 [ Vapour Pressure ]: 0.0±1.9 mmHg at 25°C [ Index of Refraction ]: 1.690 MSDS Irbesartan MSDS(Chinese) Safety Information [ Hazard Codes ]: Xn: Harmful; [ Risk Phrases ]: R22 [ Safety Phrases ]: S26-S36/37/39
[ RIDADR ]: 3276 [ Packaging Group ]: III [ Hazard Class ]: 6.1 [ HS Code ]: 2933990090 Synthetic RoutePrevious 1/9 Next 3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-2-thiophen-2-yl-1,3-diaza-spiro[4.4]non-1-en-4-one 1199814-92-0 3-[2'-(1H-t... ~82% Irbesartan 138402-11-6 Irbesartan Literature: RATIOPHARM GMBH Patent: WO2009/149734 A1, 2009 ; Location in patent: Page/Page column 14-15 ; 4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-[1,1'-Biphenyl]-2-carbonitrile 138401-24-8 4'-[(2-Buty... ~94% Irbesartan 138402-11-6 Irbesartan Literature: Satyanarayana, Bollikonda; Sumalatha, Yasareni; Sridhar, Chaganti; Venkatraman, Sundaram; Reddy, Padi Pratap Heterocyclic Communications, 2006 , vol. 12, # 5 p. 323 - 328 TRITYL IRBESARTAN 138402-10-5 TRITYL IRBESART... ~99% Irbesartan 138402-11-6 Irbesartan Literature: TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC. Patent: WO2008/27385 A2, 2008 ; Location in patent: Page/Page column 21 ; Precursor & DownStream Precursor 8 Previous 1/2 Next 3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-2-thiophen-2-yl-1,3-diaza-spiro[4.4]non-1-en-4-one Structure CAS#:1199814-92-0 3-[2'-(1H-tetra... 4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-[1,1'-Biphenyl]-2-carbonitrile Structure CAS#:138401-24-8 4'-[(2-Butyl-4-... TRITYL IRBESARTAN Structure CAS#:138402-10-5 TRITYL IRBESARTAN N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-1-[(1-oxopentyl)amino]cyclopentanecarboxamide Structure CAS#:141745-71-3 N-[(2'-Cyano[1,... DownStream 1 5-(4'-Methyl-2-biphenylyl)-1H-tetrazole structure CAS#:120568-11-8 5-(4'-Methyl-2-... Customs [ HS Code ]: 2933990090 [ Summary ]: 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% Articles70More Articles [Irbesartan in clinical practice]. Kardiologiia 52(11) , 66-74, (2012) Irbesartan is a noncompetitive angiotensin II receptor type 1 antagonist which has been successfully used for more than 10 years for the treatment of hypertensive disease. In a dose of 150-300 mg/day ... Detail Systemic sclerosis immunoglobulin induces growth and a pro-fibrotic state in vascular smooth muscle cells through the epidermal growth factor receptor. PLoS ONE 9(6) , e100035, (2014) It has been suggested that autoantibodies in systemic sclerosis (SSc) may induce the differentiation of cultured fibroblasts into myofibroblasts through platelet-derived growth factor receptor (PDGFR)... Detail Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats. Kidney Int. 88 , 109-20, (2015) Neprilysin inhibitors prevent the breakdown of bradykinin and natriuretic peptides, promoting vasodilation and natriuresis. However, they also increase angiotensin II and endothelin-1. Here we studied... Detail Synonyms 2-Butyl-3-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one Irbesartan MFCD00864464 3-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one 3-Butyl-2-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,4-diazaspiro[4.4]non-3-en-1-one 1,3-Diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- 2-Butyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one 2-Butyl-3-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-1,3-diazaspiro[4.4]non-1-en-4-one 1,3-diazaspiro4.4non-1-en-4-one, 2-butyl-3-2'-(1H-tetrazol-5-yl)1,1'-biphenyl-4-ylmethyl- 2-butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one Avapro More
|